[Anti-bacterial activity of capreomycin, kanamycin, or viomycin against drug-resistant tubercle bacilli isolated from patients].
D000995:Antitubercular Agents / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000302:isolation & purification; D013183:Sputum / Q000382:microbiology; D014376:Tuberculosis / Q000382:microbiology; D014756:Viomycin / Q000494:pharmacology*
D000995:Antitubercular Agents; D007612:Kanamycin; D014756:Viomycin